Insta
Vaccine
Zydus Cadila’s ZyCov-D anti-Covid vaccine will now be included in India’s vaccination drive as it has now begun delivering the first batch of its doses to the central government, Hindustan Times reports.
“We have started the supply of the three-dose ZyCoV-D to the Government of India. We are also planning to make it available in the private market,” the pharmaceutical firm’s official statement was quoted by the ANI.
The Drugs Controller General of India (DCGI) had given the emergency use authorization (EUA) to ZyCov-D back in August 2021.
The vaccine has been priced at Rs 358 per dose and it will be administered to individuals in three separate doses on days 0, 28 and 56 respectively.
ZyCov-D is the only needle-free Covid-19 vaccine in the world and beneficiaries have to spend Rs 1074 for the total of three doses.
The vaccine has been given a clearance for children aged above 12 years and is the first one to have received authorisation for the below-18 age group.
So far, only Covaxin made by Bharat Biotech is used to vaccinate teenagers aged between 15-18 years.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest